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Abstract
Modulation of gamma oscillations is important for the processing of information and the disruption of gamma oscillations is a promi-
nent feature of schizophrenia and Alzheimer’s disease. Gamma oscillations are generated by the interaction of excitatory and inhibi-
tory neurons where their precise frequency and amplitude are controlled by the balance of excitation and inhibition. Acetylcholine
enhances the intrinsic excitability of pyramidal neurons and suppresses both excitatory and inhibitory synaptic transmission, but the
net modulatory effect on gamma oscillations is not known. Here, we find that the power, but not frequency, of optogenetically
induced gamma oscillations in the CA3 region of mouse hippocampal slices is enhanced by low concentrations of the broad-spec-
trum cholinergic agonist carbachol but reduced at higher concentrations. This bidirectional modulation of gamma oscillations is repli-
cated within a mathematical model by neuronal depolarisation, but not by reducing synaptic conductances, mimicking the effects of
muscarinic M1 receptor activation. The predicted role for M1 receptors was supported experimentally; bidirectional modulation of
gamma oscillations by acetylcholine was replicated by a selective M1 receptor agonist and prevented by genetic deletion of M1
receptors. These results reveal that acetylcholine release in CA3 of the hippocampus modulates gamma oscillation power but not
frequency in a bidirectional and dose-dependent manner by acting primarily through muscarinic M1 receptors.
Introduction
Gamma oscillations are synchronous network oscillations in the 30–
100 Hz range found throughout the neocortex and hippocampus. The
entrainment of neuronal activity to this high-frequency oscillation is
thought to be important for the timing of spikes both within and
between different brain structures determining the ﬂow of information
(Colgin et al., 2009; Sohal et al., 2009; Ainsworth et al., 2012). The
occurrence of correlated or coherent activity at speciﬁc behavioural
time points is a critical feature of attention and sensory processing
(Fries et al., 2001; Womelsdorf et al., 2006) and underlies synaptic
plasticity required for the encoding of long-term memory (Kwag &
Paulsen, 2009). Moreover, perturbations of gamma oscillation fre-
quency, power and coherence are found in several cognitive disorders
including schizophrenia and Alzheimer’s disease (Cho et al., 2006;
Verret et al., 2012; Gonzalez-Burgos et al., 2015) indicating the
importance of gamma oscillations for cognitive functions.
Generation of gamma oscillations in vivo can be achieved by
reciprocally connected populations of excitatory and inhibitory neu-
rons (Penttonen et al., 1998; Atallah & Scanziani, 2009; Cardin
et al., 2009; Sohal et al., 2009) (see Fig. 4A). This anatomical
arrangement occurs throughout the neocortex and hippocampus
where inhibitory fast-spiking parvalbumin-positive basket cells (PV
BCs) provide feedback inhibition of excitatory pyramidal cells
(PCs). In the hippocampus gamma oscillations are commonly
observed ‘nested’ on the phase of theta oscillations (Lisman & Jen-
sen, 2013), but in vitro gamma oscillations may also be induced by
application of glutamatergic or cholinergic agonists (Fisahn et al.,
1998; Palhalmi et al., 2004). Gamma oscillation phase can be
entrained by strong excitatory or inhibitory input to the network
(Akam et al., 2012), which is proposed to be a mechanism for the
generation of different frequencies of gamma within the same brain
region (Colgin et al., 2009; Jadi & Sejnowski, 2014; Lasztoczi &
Klausberger, 2014; Schomburg et al., 2014). However, in compar-
ison to their generation, much less is known about the mechanisms
for modulation of gamma oscillations.
The release of acetylcholine in the neocortex and hippocampus
activates muscarinic and nicotinic receptors that regulate the pro-
cessing of information within these circuits (Hasselmo, 2006; Teles-
Grilo Ruivo & Mellor, 2013). Muscarinic and nicotinic receptors are
targeted to speciﬁc compartments that enable each subtype to con-
trol the function of selective nodes within a circuit. For example,
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M1 muscarinic receptors are principally located on somatic and den-
dritic compartments of PCs (Levey et al., 1995; Yamasaki et al.,
2010), with some evidence for expression in interneurons (Cea-del
Rio et al., 2010; Yi et al., 2014), where they increase excitability
by causing the opening of non-selective cationic channels and
inhibiting K+ channels such as M channels and SK channels (Madi-
son et al., 1987; Fisahn et al., 2002; Buchanan et al., 2010).
Genetic deletion of M1 receptors or pharmacological inhibition of
muscarinic receptors disrupts memory (Blokland et al., 1992; Anag-
nostaras et al., 2003; Atri et al., 2004; Wess, 2004; Green et al.,
2005), whereas administration of muscarinic receptor agonists or
acetylcholinesterase inhibitors in Alzheimer’s disease (Bodick et al.,
1997; McGleenon et al., 1999) or muscarinic receptor agonists in
cognitively impaired humans (Shekhar et al., 2008; Nathan et al.,
2013) can improve memory. Cholinergic agonists and acetylcholi-
nesterase inhibitors induce gamma oscillations in vitro (Fisahn et al.,
2002; Spencer et al., 2010), but their role in modulating pre-existing
gamma oscillations and the cholinergic receptor subtypes involved
are less well characterised.
To study the mechanisms underlying the modulation of gamma
oscillations we made use of in vitro and in silico models of gamma
oscillations. These systems have previously been used to investigate
the mechanisms for the generation of gamma oscillations but have
rarely been employed to determine the mechanisms by which they
might be modulated. Using optogenetically induced gamma oscilla-
tions in hippocampal CA3 and a mathematical network model we
show that acetylcholine regulates the power, but not frequency, of
gamma oscillations in a bidirectional, dose-dependent manner which
is mediated by activation of muscarinic M1 receptors.
Materials and methods
Ethical approval
All experiments were performed in accordance with the UK Animal
Scientiﬁc Procedures Act (1986) and local guidance from the Home
Ofﬁce Licensing Team at the University of Bristol. The protocol
was approved by the Animal Welfare and Ethics Review Board at
the University of Bristol.
Transfection
Fifty-three wild-type, male, C57/BL6 mice or muscarinic M1 recep-
tor KO mice (M1 KO, bred on a C57/BL6 background; line 1784,
Taconic (Fisahn et al., 2002)) were used with experiments inter-
leaved for wild-type and M1 KOs. p21–24 wild-type mice or p25–
40 M1 KO mice underwent stereotaxic surgery to inject virus into
the CA3 region of the hippocampus. Under inhalation anaesthesia
(1–3% O2, 0.5–2% isoﬂuorane), animals were given stereotaxic
injections of rAAV5-CaMKIIa-hChR2 (H134R)-EYFP virus (Virus
Vector Core; 0.5 lL of 4 9 1012 T.U./mL) at the following coor-
dinates: (from bregma, in mm) posterior 2.3, lateral 2.2, ventral 2.2
(wild-type mice) and posterior 2.46–2.80, lateral 2.60–2.85, ventral
2.36–3.00 (M1KO mice, coordinates chosen based on animal age).
To assess construct expression, animals were anaesthetised with
intraperitoneal injection of sodium pentobarbital (150 mg/kg) and
perfused transcardially with 4% paraformaldehyde (Sigma-Aldrich)
at 7, 21 and 35 days after transfection. Sixty-micrometre-thick brain
sections were taken with the aid of a freezing microtome and
mounted with Vectashield medium (Vector Laboratories) containing
DAPI allowing the visualisation of cell nuclei alongside ChR2-YFP
expression under an epiﬂuorescence microscope.
Slice electrophysiology
Acute hippocampal slices were prepared 7–40 days after transfection
for initial characterisation and 27–53 days after transfection for all
drug concentration comparisons. Animals were decapitated follow-
ing cervical dislocation, the brain removed and hippocampi dis-
sected in ice-cold modiﬁed ACSF containing (in mM): 252 sucrose,
2.5 KCl, 26 NaHCO3, 1 CaCl2, 5 MgCl2, 1.25 NaH2PO4 and 10
glucose. Transverse hippocampal slices of 400 lm thickness were
cut using a microslicer (Leica VT1200S) and stored in standard
ACSF containing (in mM): 119 NaCl, 10 glucose, 26 NaHCO3, 2.5
KCl, 1 NaH2PO4, 2.5 CaCl2 and 1.3 MgSO4 at room temperature
for at least 1 h prior to recording. All solutions were saturated with
95% O2, 5% CO2.
For recording, slices were transferred to a dual perfusion style
submerged chamber for increased metabolic supply (RC-27L; War-
ner Instruments). Standard ACSF was perfused at a rate of
8.5 mL/min and recording chamber temperature was maintained at
32–34 °C. Slices were visualised using infrared differential interfer-
ence-contrast or ﬂuorescence microscopy and YFP ﬂuorescence
excited with a 505-nm-wavelength LED. Channelrhodopsin was
excited with a 470-nm-wavelength LED through the 4 9 objective
on the microscope. Local ﬁeld potential (LFP) recordings were
made using borosilicate glass pipettes with resistance 3–6 MO
when ﬁlled with standard ACSF. LFPs were recorded with a multi-
clamp 700A ampliﬁer (Molecular Devices), ﬁltered with a Bessel
low-pass ﬁlter at 200 Hz and sampled at 10 kHz using a Micro
1401 data acquisition board (CED). No correction was made for
background 50 Hz noise. Recordings were made using Signal2
software (CED) and analysed ofﬂine using custom written pro-
grams in MATLAB.
Mathematical model
The model for a single cell (node in the network) was based on the
model of Kopell et al. (Kopell et al., 2010) which uses the
Hodgkin–Huxley Eqn 1:
C
dV
dt
¼ gNam1 Vð Þ3h VNa  Vð Þ þ gKn4 VK  Vð Þ þ gL VL  Vð Þ
þ IKm þ Isyn þ I; ð1Þ
IKm ¼ gKmkKm VKm  Vð Þ: ð2Þ
The membrane potential of both PCs and interneurons is gov-
erned by the interaction of sodium (Na), potassium (K) and leak cur-
rents (L) as well as an applied current (I). Pyramidal cells also
contain an additional m-current potassium conductance modelled as
in Nowacki et al. (2011) and using VKm = 35 mV: Eqn (2). The
applied current takes a variety of forms including step, ramp and
sine wave functions. In the model, capacitance density (C) is mea-
sured in lF/cm2, voltage (V) in mV and time (t) in ms. The vari-
ables gNa, gK and gL are the maximal ionic conductances (mS/cm
2).
m, h and n are rate functions which determine the gating characteris-
tics of the respective channel and are identical to those given in
Kopell et al. (2010). The gating variables are different between
pyramidal and interneurons and determine their distinct ﬁring prop-
erties. Initial model parameters based on Kopell et al. (2010) are
given in Table 1.
Cells were synaptically coupled in an all-to-all conﬁguration using
the following expression:
Isyn ¼ gijsi tð Þ Vrev  Vj
 
; ð3Þ
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where gij is the maximal conductance of the synapse, si is the gating
variable and Vrev is the reversal potential of the synapse. Finally, there
was stochastic external drive applied to the network to simulate noise.
A network of 80 PCs and 20 interneurons was used to simulate oscil-
latory activity in the model system. Fewer neurons reduced the power
and therefore reliability of gamma oscillations, whereas more neurons
increased simulation time without increasing gamma power. Differen-
tial equations were solved in MATLAB using the mid-point method.
To make comparisons with in vitro data, Eqn 4 (Bedard et al.,
2010) was used to give an approximation of LFP.
VLFP ¼ Re4p
X
j
Ij
rj
; ð4Þ
where Re is the extracellular resistivity assumed to be 230 O/cm, Ij
is the sum of the currents of cell j and rj is taken from a normal dis-
tribution representing distance between cell and position where LFP
is recorded. A subpopulation of 40 PCs and 10 interneurons was
used to calculate LFP.
Analysis
Fast fourier transform (FFT) of LFP data was performed to generate
power spectral densities (PSD) using the chronux toolbox (http://
chronux.org, Mitra & Bokil, 2008) in MATLAB and a 5 taper mul-
titaper estimate. In all experiments baseline PSDs with no stimula-
tion were subtracted from data with stimulation input to remove
background noise. In every case baseline and stimulation PSDs were
calculated from downsampled data (1 kHz) and taken from an aver-
age of six 2.5 s frames. Subtracted PSDs were smoothed with a
moving average ﬁlter with span of 35 data points. Gamma oscilla-
tion power was calculated as the integral of the PSD between 30
and 100 Hz and theta oscillation power between 4 and 12 Hz. The
peak gamma oscillation frequency was measured at the maximum
power between 30 and 100 Hz. Gamma and theta oscillation power
was baseline subtracted within each slice experiment.
Statistics
Data are plotted as mean  SEM throughout the manuscript. Kol-
mogorov–Smirnov test showed data were normally distributed. Data
for drug concentration comparisons were then analysed by one-way
ANOVA followed by post hoc two-sample t-tests assuming unequal
variances using Holm–Bonferroni correction to test the null hypothe-
sis that data were the same as baseline for each pharmacological
manipulation. Experimental numbers for statistical analysis were
taken as the number of slices used. *Denotes P < 0.05, **P < 0.01,
***P < 0.001 and no star denotes P > 0.05.
Results
Optogenetically induced gamma oscillations in hippocampal
slices
Excitation of local excitatory and inhibitory networks has been
shown to produce gamma-frequency oscillations in in vitro acute
brain slice preparations. In the hippocampus, application of gluta-
matergic or cholinergic agonists provides excitation that generates
gamma oscillations in the 30–50 Hz range (Buhl et al., 1998;
Fisahn et al., 1998; Palhalmi et al., 2004). However, these persistent
gamma oscillations, although robust and therefore amenable to
experimental manipulation, are not observed in vivo. More recently,
gamma oscillations have been evoked in vivo and in vitro using
transient activation of channelrhodopsin (ChR) to provide excitatory
drive to the network. This has been achieved in slices of neocortex
or hippocampus by expressing ChR in neurons which are then stim-
ulated by step, ramp or sinusoidal waveforms of light (Adesnik &
Scanziani, 2010; Akam et al., 2012; Pastoll et al., 2013; Butler
et al., 2016). In particular, the use of an optogenetically driven
theta-frequency sine wave produces theta-nested high-frequency
gamma comparable to that found in vivo. The use of optogenetics to
induce gamma oscillations provides a system where the modulation
of gamma oscillations by pharmacological activation of cholinergic
receptors may be tested. Therefore, we developed an optogenetic
Table 1. Model parameters. All parameters were based on those used in Kopell et al. (2010). Where changes were made the original values from Kopell et al.
(2010) are given in bold brackets for comparison. Changes in sodium and potassium conductance and reversal potentials were chosen to produce waveforms
closer to those we observed experimentally and were within the ranges used in other similar biophysical modelling studies (Traub et al., 1994; Wang & Buz-
saki, 1996; Ermentrout & Kopell, 1998)
Parameters
Value
UnitExcitatory cells Inhibitory cells
Number of cells Npr 80
Nin 20
Capacitance C 1 1 lF/cm2
Conductances Sodium gNa 50 (100) 35 mS/cm2
Potassium gK 20 (80) 9 mS/cm2
Leak gL 0.1 0.1 mS/cm2
M-current gKm 0.5 mS/cm
2
Reversal potentials Sodium VNa 50 55 mV
Potassium VK 70 (100) 90 mV
Leak VL 67 65 mV
M-current VKm 85 mV
Synaptic conductances E to E gE-E 0.5 (0) mS/cm
2
I to E gI-E 1.5 mS/cm
2
I to I gI-I 0.7 (0.5) mS/cm
2
E to I gE-I 1.5 (0.5) mS/cm
2
Synaptic reversal potentials Vrev 0 80 mV
Synaptic time constants Rise time sR 0.1 0.3 ms
Decay time sD 3 9 ms
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system for inducing gamma oscillations in the CA3 region of acute
hippocampal slices.
ChR expression was targeted preferentially to CA3 PCs by stereo-
taxic injection of a viral vector (AAV5) containing ChR (hChR2
(H134R)) tagged with YFP under the control of the CaMKIIa pro-
moter into the dorsal CA3 region at p21 (see Materials and methods).
YFP expression increased over 35 days post-injection (d.p.i, Fig. 1A)
after which expression levels plateaued and appeared strongest in
stratum radiatum due to higher membrane density. Functional ChR
expression was assessed by LFP recording in stratum radiatum in the
CA3 area (Fig. 1B). Ten-millisecond optical stimulation (470 nm) of
a circular area encompassing most of the slice evoked LFP responses
comprised of slow (onset > 8 ms after the start of light stimulation)
and fast (onset < 5 ms after the start of light stimulation) components
which were blocked by NBQX (10 lM) and TTX (1 lM), respec-
tively, and were therefore termed excitatory post-synaptic potentials
(EPSPs) and ﬁbre volleys (Fig. 1C). A residual LFP response was
observed in the presence of TTX due to charge ﬂowing through ChR.
EPSP amplitude increased with increasing light intensity which pla-
teaued around 600–800 lW (Fig. 1D).
We then tested the relative efﬁcacy of step, ramp or sinusoidal
waveforms of light stimulation for the generation of gamma oscilla-
tions in hippocampal slices. A representative example of a comparison
made in a single slice is shown in Fig. 1E. A 1-s step waveform
(Fig. 1Ei) elicited gamma oscillations with peak frequency 61.5 Hz,
but had a low initial power that attenuated rapidly (average power
1.28 9 105 mV2). A ramp stimulus to the same peak light intensity
as the step stimulus induced gamma oscillations with similar peak fre-
quency (62.4 Hz) but with higher average power (2.16 9 104 mV2)
and less attenuation (Fig. 1Eii). Moreover, gamma oscillation peak
frequency did not vary over the course of the ramp stimulation. Hip-
pocampal gamma oscillations in vivo are often observed ‘nested’
within an overlying theta (4–12 Hz) oscillation (Bragin et al., 1995).
We mirrored this in our preparation by stimulating the slice with a
5 Hz or 8 Hz sinusoidal waveform that had the same average light
intensity as the step waveform (Fig. 1Eiii and Eiv) (Pastoll et al.,
2013). These stimulations reliably elicited gamma oscillations of
higher peak frequency (75.7 and 78.7 Hz, respectively) and compara-
ble average power (6.80 9 105 mV2 and 8.90 9 105 mV2) with
minimal attenuation. Gamma oscillation peak frequency reduced over
sequential theta cycles and therefore mean gamma oscillation peak fre-
quency was calculated across the entire 1 s stimulation period (aver-
age peak frequency for 5 Hz stimulation was 65.7  3.0 Hz, n = 54).
In accordance with the YFP expression data (Fig. 1A), expression
levels of functional ChR were only sufﬁcient to reliably generate
gamma oscillations in response to 5 Hz stimulation around 28 d.p.i.
and induced gamma oscillation power was consistent for longer peri-
ods of expression post-injection (average gamma oscillation power
7.98 9 105  1.27 9 105 mV2, range 27–53 d.p.i., n = 54).
Given the physiological relevance of theta frequency for the genera-
tion of gamma oscillations, the 5 Hz sinusoidal waveform stimulation
protocol was selected for all further experiments and the maximum
light stimulation intensity was set to the value that elicited a half maxi-
mal EPSP response (Fig. 1D).
In our experimental model, gamma oscillations are hypothesised
to be generated by the direct reciprocal interaction between gluta-
matergic CA3 PCs and GABAergic PV BCs (Adesnik & Scanziani,
2010; Akam et al., 2012; Pastoll et al., 2013; Butler et al., 2016).
We tested this by application of glutamatergic or GABAergic antag-
onists to gamma oscillations induced by 5 Hz, theta-frequency light
stimulation. The AMPA/kainate receptor antagonist NBQX was bath
applied at increasing concentrations from 0.1 to 10 lM (Fig. 2A and
B). Gamma oscillation power was decreased at concentrations
≥1 lM without affecting peak frequency and was reversed after
washout of NBQX. The GABAA receptor antagonist picrotoxin
(PTX) also decreased the power of gamma oscillations in a dose-
dependent and reversible manner without affecting peak frequency
(Fig. 2C and D). These results support a model where optogeneti-
cally induced theta-nested gamma oscillations are generated by
reciprocal excitatory and inhibitory synaptic connectivity within the
CA3 network (Buzsaki & Wang, 2012).
Modulation of optogenetically induced gamma oscillations by
carbachol
We next sought to determine whether acetylcholine could modulate
gamma oscillations in our experimental system. The non-hydrolysa-
ble analogue of acetylcholine, carbachol (CCh), was bath applied at
increasing concentrations from 50 nM to 10 lM. Low concentrations
of CCh (0.05 and 0.1 lM) caused an increase in gamma oscillation
power, whereas higher concentrations (3 and 10 lM) caused a
decrease in gamma oscillation power (Fig. 3A and B). The peak aver-
age frequency of gamma oscillations was not affected by any concen-
tration of CCh (Fig. 3A and B) and neither was the peak frequency
during the ﬁrst theta cycle nor the attenuation of gamma frequency
across consecutive theta cycles (Fig. S1). The effects of CCh on the
power of gamma oscillations were fully reversed on washout of CCh
and, furthermore, time-matched control experiments showed that
gamma oscillation power and peak frequency did not vary over the
course of experiments (Fig. 3C). In vivo observations indicate that
gamma oscillation power is dependent on theta oscillation power
(Bragin et al., 1995). Therefore, we next analysed whether CCh had
any effect on the power of theta oscillations. We found that theta
oscillation power remained constant for all concentrations of CCh
application (Fig. 3D) indicating that CCh-induced changes in gamma
oscillation power were not attributable to changes in theta oscillation
power. In addition, neither theta nor gamma power was increased out-
side of optogenetic stimulation by these concentrations of carbachol.
These results show that CCh induces a bidirectional dose-dependent
effect on the power of gamma oscillations that is independent of
underlying theta oscillation power.
Modelling the modulation of gamma oscillations by
acetylcholine
Acetylcholine activates nicotinic a4b2, a3b4 and a7 receptors and
muscarinic M1, M2, M3 and M4 receptors in the hippocampus
causing a range of effects including inhibition of potassium channels
and depolarisation (M1 and M3) and regulation of presynaptic cal-
cium channels and release of neurotransmitter (M2, M4, a4b2, a3b4
and a7) (Teles-Grilo Ruivo & Mellor, 2013). Acetylcholine and its
non-hydrolysable analogue carbachol have different afﬁnities and
efﬁcacies at these cholinergic receptor subtypes (Jensen et al.,
2003). To investigate the mechanism underlying cholinergic modula-
tion of gamma oscillations and identify which cholinergic receptors
are involved we developed a biophysical model of CA3 comprising
a network of single-compartment Hodgkin-Huxley type neurons,
based on the work of Kopell et al. (see Materials and methods)
(Kopell et al., 2010). Eighty PCs and 20 interneurons were all-to-all
connected (Fig. 4A), ﬁred action potentials (Fig. 4B) and exhibited
coordinated network behaviour (Fig. 4C). As previously described
in experimental and theoretical studies (Kopell et al., 2010; Akam
et al., 2012), step input to the PCs (1.25 lA/cm2) drove the network
to ﬁre at gamma frequency (Fig. 4Ci) as did theta-frequency
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Fig. 1. Optogenetic induction of gamma oscillations. (A) Expression of ChR2-EYFP over time (d.p.i. in top left of each image) after injection of rAAV5-CaM-
KIIa-hChR2 (H134R)-EYFP virus into CA3 region. Scale bar is 500 lm. (B) Schematic diagram illustrating recording electrode placement within stratum radia-
tum in CA3 of acute hippocampal slice. (C) Example LFP responses to 10 ms light stimulation (470 nm, 581 lW) during control and following NBQX
(10 lM) or TTX (1 lM) application. (D) Amplitude of the LFP response plotted against light intensity (n = 10 slices from eight animals). (E) Comparison of
optogenetic protocols for induction of gamma oscillations. First row: Schematic of light stimulation protocol. Column i: 1 s step; column ii: 1 s ramp; column
iii: 5 Hz sine wave; column iv: 8 Hz sine wave. Subsequent rows show unﬁltered LFP, LFP bandpass ﬁltered between 30 and 100 Hz, power spectral density
plots and spectrograms (maximum power given in top right). Data shown are from a single slice. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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Fig. 2. Inhibition of excitatory and inhibitory synaptic connections reduces the power of theta-nested gamma oscillations. (A) Example unﬁltered (top) and
bandpass ﬁltered (bottom) LFP traces showing response to 5 Hz sinusoidal light stimulation before, during and after NBQX (10 lM). (B) Gamma oscillation
power but not peak frequency was reduced by NBQX at concentrations of 3 and 10 lM (n = 9 slices from six animals; P = 5.89 9 105 and 1.92 9 108
compared to baseline for 3 and 10 lM, respectively, P > 0.05 for all other concentrations). (C) Example unﬁltered (top) and bandpass ﬁltered (bottom) LFP
traces showing response to 5 Hz sinusoidal light stimulation before, during and after picrotoxin (PTX, 10 lM). (D) Gamma oscillation power but not peak fre-
quency was reduced by picrotoxin at concentrations of 3, 10 and 30 lM (n = 8 slices from six animals; P = 0.00265, 0.00204 and 0.00349 compared to base-
line for 3, 10 and 30 lM, respectively, P > 0.05 for all other concentrations). **P < 0.01, ***P < 0.001.
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Fig. 3. Carbachol induces a dose-dependent bidirectional change in the power of theta-nested gamma oscillations. (A) Example unﬁltered (top) and bandpass ﬁltered
(2nd row) LFP traces showing response to 5 Hz sinusoidal light stimulation before, during and after carbachol (0.1 and 10 lM). Power spectral density plots and spec-
trograms (maximum power given in top right) are shown below for an example experiment. (B) Gamma oscillation power but not peak frequency was increased at low
concentrations (0.1 lM) of carbachol but reduced at higher concentrations (3 and 10 lM) (n = 11 slices from nine animals; P = 0.00383, 0.00350 and 5.950 9 108
compared to baseline for 0.1, 3 and 10 lM, respectively, P > 0.05 for all other concentrations). (C) Gamma oscillation power and peak frequency were unchanged in
time-matched control experiments (n = 4 slices from three animals; P > 0.05 for all time points). (D) Theta oscillation power was not changed by any concentration of
carbachol (n = 11 slices from nine animals; P > 0.05 for all concentrations). **P < 0.01, ***P < 0.001. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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sinusoidal inputs (2.5 lA/cm2 maximum amplitude) at 5 Hz or
8 Hz (Fig. 4Cii, Ciii), thus recapitulating key characteristics of the
experimental data. To allow comparisons with our experimental
results, we used the 5 Hz sinusoidal input in all further simulations
which produced gamma oscillations with peak frequency 41.2 Hz
and average power 3.94 9 104 mV2.
We next tested two hypothesised effects of acetylcholine on
gamma oscillations: (i) depolarisation of PCs caused by activation
of a non-selective cationic conductance and inhibition of KCNQ
channels (M-current) which model core aspects of muscarinic M1
receptor activation (Madison et al., 1987; Fisahn et al., 2002), and
(ii) reduction in inhibitory synaptic transmission which models an
aspect of muscarinic M2 and nicotinic a4b2, a3b4 and a7 receptor
activation (Alkondon & Albuquerque, 2001; Ji et al., 2001; Szabo
et al., 2010; Tang et al., 2011; Teles-Grilo Ruivo & Mellor, 2013).
Inhibition of M-current in the model had no effect on gamma oscil-
lation power or frequency (Fig. S2). To model the effects of activat-
ing a non-selective cationic conductance (which could be voltage or
calcium dependent), a constant depolarising input current of increas-
ing amplitude was applied to PCs in addition to the theta-frequency
sinusoidal current injection (Fig. 5A). 1 lA/cm2 constant input cur-
rent caused PCs to depolarise from 72.3  1.4 mV to
69.9  2.1 mV (Fig. 5B) and increased the power of gamma
oscillations (Fig. 5C and D). As input current was increased, PCs
were more depolarised (to 65.3  0.8 mV at 6 lA/cm2) (Fig. 5B)
and the power of gamma oscillations was reduced (Fig. 5C and D).
The peak gamma oscillation frequency remained relatively unaf-
fected, within a range of input currents, exhibiting only a slight
increase (Fig. 5D). We then tested the mechanism for the biphasic
effect on gamma oscillation power by analysing the ﬁring properties
of neurons during theta-frequency excitation. 1 lA/cm2 input current
to PCs caused both PCs and PV BCs to increase their probability of
ﬁring across the theta cycle but with the timing of spikes still
entrained to gamma frequency (Fig. 5E). However, as the input cur-
rent was increased up to 6 lA/cm2 the entrainment to gamma fre-
quency was lost such that PCs, and therefore PV BCs, ﬁred at much
higher frequencies and the network became desynchronised (Gulyas
et al., 2010; Fig. 5E). These results indicate that activation of M1
mAChRs is sufﬁcient to replicate the experimental data for the
biphasic modulation of gamma oscillation power by carbachol and
point towards a mechanism involving an increase in non-selective
cation conductance rather than inhibition of M-current.
To model the effects of reducing inhibitory synaptic transmission
the inhibitory-to-excitatory synaptic conductance (gI-E) was reduced
in the model (Fig. 6A). Reducing gI-E from 1.5 to 0.9 mS/cm2 pre-
vented gamma oscillations below a value of 1.1 mS/cm2 (Fig. 6B
and C). Analysis of neuronal ﬁring during theta-frequency stimula-
tion revealed that reducing gI-E below 1.1 mS/cm2 caused PV BCs
to depolarise sufﬁciently to inactivate Na+ channels and therefore
stop ﬁring action potentials leading to a complete loss of rhythmic
network activity (Fig. 6D). These results suggest that a critical level
of gI-E is necessary for gamma oscillations, but above this threshold
gI-E does not modulate either their power or frequency.
Overall, these simulations predict that the principal effect of
acetylcholine – namely, the bidirectional dose-dependent increase
and decrease in gamma oscillation power – could be explained
solely by the activation of M1 mAChRs, although it is possible that
the decrease in gamma oscillation power at higher concentrations
could also be partly mediated by activation of other cholinergic
receptors that depress inhibitory synaptic transmission.
Interestingly, both the experimental and simulation data showed a
remarkable stability in gamma oscillation frequency despite
considerable modulation of gamma oscillation power across the range
of carbachol concentrations (Fig. 3) and current injections (Fig. 5),
respectively. The frequency of gamma oscillations has been proposed
to be principally governed by the activity of, and therefore synaptic
input to, interneurons during ongoing gamma oscillations (Whitting-
ton et al., 1995; Wang & Buzsaki, 1996; Jadi & Sejnowski, 2014),
and therefore we hypothesised that stable gamma oscillation fre-
quency could result from stable synaptic input to interneurons during
gamma oscillations. We tested this in the biophysical model by
increasing the interneuron-to-interneuron synaptic conductance (gI-I
from 0.7 to 1.1 mS/cm2), which produced an increase in the net
synaptic current (calculated by summating the excitatory and inhibi-
tory synaptic currents during the simulation period) during gamma
oscillations in interneurons but not in PCs (Fig. 7A). Furthermore,
net synaptic current remained fairly constant across the range of con-
stant current injections to the PCs found to modulate gamma oscilla-
tion power when gI-I = 0.7 mS/cm2, but in contrast, the net synaptic
current increased substantially when gI-I = 1.1 mS/cm2 as the con-
stant current injection was increased. This suggested that increasing
inhibitory synaptic conductance between interneurons reduces the sta-
bility of net synaptic current to interneurons during gamma oscilla-
tions and therefore the stability of gamma oscillation frequency.
Indeed, when we analysed the gamma oscillation frequency stability
across the range of depolarising current injections we found that
using a low gI-I produced relatively stable frequencies, but when gI-I
was increased to 1.1 mS/cm2 or 1.5 mS/cm2 gamma oscillation fre-
quency was much less stable with increasing depolarising current
(Fig. 7B and C). Similarly, using an alternative approach to reduce
the excitatory–inhibitory synaptic balance to interneurons, we found
that reducing excitatory synaptic conductance onto interneurons (gE-
I) from 1.5 mS/cm2 to 1.0 mS/cm2 or 0.5 mS/cm2 also produced
much less stable gamma oscillation frequencies (Fig. 7B and C).
These results suggest that the gamma oscillation generating network
in CA3 of our acute hippocampal slices contains interneurons with
relatively large excitatory compared to inhibitory synaptic inputs.
M1 mAChRs mediate the modulation of gamma oscillations by
acetylcholine
To test the model predictions we used a combination of pharmaco-
logical and genetic approaches in the experimental optogenetic
model of theta-nested gamma oscillations. The simulations predict
that M1 mAChR activation is the principal driver of cholinergic
modulation of gamma oscillations, so we tested if M1 mAChR acti-
vation was sufﬁcient and necessary using a selective M1 mAChR
agonist and M1 mAChR knockout mice.
The M1 mAChR allosteric agonist GSK-5 (Budzik et al., 2010;
Dennis et al., 2015) was applied to slices in increasing concentra-
tions from 50 nM to 3 lM. In an almost identical manner to CCh
(Fig. 3), GSK-5 produced a bidirectional dose-dependent change in
the power of gamma oscillations (Fig. 8A and B). Gamma oscilla-
tion power increased following applications of 50 nM or 100 nM
GSK-5, whereas 1 lM or 3 lM caused a decrease in power (Fig. 8A
and B). We have previously found that GSK-5 is not readily
removed from slices on washout (Dennis et al., 2015) and this was
also true for the effects on gamma oscillation power. Again, similar
to CCh, there was no change in peak gamma oscillation frequency
at any concentrations of GSK-5 tested (Fig. 8B). These results sup-
port the mathematical model predictions that M1 mAChRs play a
key role in the modulation of gamma oscillations by acetylcholine.
To test whether any other cholinergic receptors are important for
the modulation of gamma oscillations, we made use of M1 mAChR
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Fig. 4. Theta-nested gamma oscillations in a biophysical network model. (A) Schematic representation for model connectivity between excitatory (EN) and
inhibitory (IN) neurons. (B) Spiking characteristics of excitatory (top, red) and inhibitory (bottom, blue) neurons within the network. (C) Network behaviour in
response to step (Ci) or 5 Hz (Cii) or 8 Hz (Ciii) input to excitatory cells with maximal amplitude 2.5 lA/cm2. First row: Schematic of current injection proto-
col; second row: raster plot of spiking for a network of 80 excitatory (red) and 20 inhibitory (blue) neurons; third row: LFP; fourth row: power spectral density
plots; ﬁfth row: spectrograms (maximum power given in top right). [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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Fig. 5. Modelling the effect of M1 mAChR activation on gamma oscillations. (A) Schematic representation of depolarising current given to excitatory neurons
within the network to model the action of M1 mAChRs. (B) Increasing the amount of current injection depolarised pyramidal neurons in the mathematical model.
(C) Power spectral density plots for increasing current injections. (D) Gamma oscillation power was increased at low current injection (1 lA/cm2), but reduced at
higher current injections (4 and 6 lA/cm2) (n = 7; P = 2.24 9 104, 5.09 9 104, 7.82 9 1010 and 5.56 9 1011 compared to baseline for 1, 2, 4, 6 and 8 lA/
cm2, respectively). (E) Example spiking output during sinusoidal input to pyramidal cells (black trace overlaid) for excitatory (top) and inhibitory (bottom) neurons
over the range of constant current injections given to pyramidal neurons. ***P < 0.001. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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Fig. 6. Modelling the effect of M2 mAChR activation on gamma oscillations. (A) Schematic representation of reduction in inhibitory–excitatory synaptic con-
ductance (gI-E) within the network to model the action of M2 mAChRs. (B) Power spectral density plots for reduced gI-E. (C) Gamma oscillation power was
decreased for reduced gI-E (1.0 and 0.9 mS/cm2) (n = 7; P = 1.59 9 1025 and 1.37 9 1023 compared to baseline for 1.0 and 0.9 mS/cm2, respectively). (D)
Example spiking output during sinusoidal input to pyramidal cells (black trace overlaid) for excitatory (top) and inhibitory (bottom) neurons over the range of
gI-E. ***P < 0.001. [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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knock-out (M1KO) mice (Fisahn et al., 2002; Buchanan et al.,
2010; Dennis et al., 2015). ChR was expressed in the hippocampus
following viral injection using the same methods as wild-type mice
and gamma oscillations of similar peak frequency and power were
elicited by 5 Hz sinusoidal stimulation. In slices from M1KO mice
the effects of CCh application were absent with no increase or
decrease in the power or peak frequency of gamma oscillations
(Fig. 8C and D). These results strongly indicate that M1 mAChRs
are the principal mediators of the bidirectional dose-dependent
effects of acetylcholine on gamma oscillations.
Discussion
In this study we employed two separate approaches to investigate
the modulation of gamma oscillations by acetylcholine. We ﬁrst
developed a model for studying theta-nested gamma oscillations
using theta-frequency optogenetic stimulation of acute hippocampal
slices (Pastoll et al., 2013; Butler et al., 2016). We found that the
broad-spectrum cholinergic agonist carbachol modulates gamma
oscillation power, but not frequency, in a bidirectional and dose-
dependent manner. We then tested the mechanism for this bidirec-
tional modulation using a mathematical biophysical network model
for gamma oscillations (Kopell et al., 2010) which predicted that
M1 mAChRs were the most likely mediators for the effects of
acetylcholine. Finally, we tested the model predictions and found
that activation of M1 mAChRs is both sufﬁcient and necessary for
the modulation of gamma oscillations by acetylcholine.
Theta-nested gamma oscillations in CA3 region of the hippocampus
are generated in vivo by the coordinated interactions of excitatory and
inhibitory neurons which are triggered by excitation of both groups of
neurons phase locked to the theta cycle (Buzsaki & Wang, 2012). This
ensures that gamma power strongly covaries with theta power for
theta-nested gamma (Bragin et al., 1995). Coordinated excitation of
excitatory and inhibitory neurons may also be provided in vitro in a
persistent manner by different pharmacological mechanisms including
stimulation of kainate receptors, metabotropic glutamate receptors or
muscarinic receptors (Buhl et al., 1998; Fisahn et al., 1998; Palhalmi
et al., 2004). Although gamma oscillations are not thought to be trig-
gered directly by activation of these receptors in vivo, this strongly
suggests that cholinergic receptor activation can modulate theta-nested
gamma oscillations. The power of theta oscillations in the hippocam-
pus is modulated by cholinergic innervation (Lee et al., 1994; Vande-
casteele et al., 2014) providing one indirect mechanism for the
modulation of gamma oscillations by acetylcholine. In contrast, we
demonstrate a direct mechanism for the modulation of gamma oscilla-
tions where theta oscillation power and frequency remain constant.
We found that carbachol modulates the power of gamma oscilla-
tions in a bidirectional manner which initially suggested two distinct
modulatory mechanisms mediated by multiple cholinergic receptors
with different efﬁcacies. Two potential mechanisms are an increase
in excitability caused by activation of M1/M3 mAChRs and the
decrease in inhibitory synaptic conductance caused by activation of
M2 mAChRs or a4b2, a3b4 or a7 nicotinic receptors. Indeed, the
power and frequency of persistent gamma oscillations generated by
kainate have been shown to be modulated by nicotinic receptors
(Wang et al., 2015). However, the frequency of gamma oscillations
was unchanged by carbachol. This was surprising because acetyl-
choline has effects on both PV BC excitability and inhibitory synap-
tic transmission (Alkondon & Albuquerque, 2001; Ji et al., 2001;
Szabo et al., 2010; Tang et al., 2011; Teles-Grilo Ruivo & Mellor,
2013; Yi et al., 2014), which are key determinants of gamma oscil-
lation frequency (Whittington et al., 1995; Wang & Buzsaki, 1996;
Pyramidal cell InterneuronA
CB
Fig. 7. Gamma oscillation frequency stability is governed by synaptic input to interneurons. (A) Net synaptic current density (excitatory synapses are charac-
terised by positive current and vice versa) during modelled gamma oscillations induced by theta-frequency stimulation became more strongly negative in pyra-
midal cells (PCs; left) but less so in interneurons (right) as the constant depolarising current increased. Increasing inhibitory-to-inhibitory conductance, gI-I,
from 0.7 mS/cm2 to 1.1 mS/cm2 produced no change in net synaptic current density in PCs, but became more negative in interneurons particularly with large
constant depolarising current. (B) Gamma oscillation frequency was less stable across a range of constant current injections when excitatory–inhibitory synaptic
balance was reduced. In control conditions (gI-I = 0.7 mS/cm2, gE-I = 1.5 mS/cm2), gamma oscillation frequency increased only slightly with applied depolar-
ising current (ﬁtted plots (left) and slopes (right)). When E-I balance was altered by either increasing gI-I or reducing gE-I gamma oscillation frequency
increased strongly with applied depolarising current (n = 7; P = 8.71 9 103, 6.77 9 104, 5.10 9 103, 2.54 9 108 for slope comparison control to gI-
I = 1.1 mS/cm2, gI-I = 1.5 mS/cm2, gE-I = 1.0 mS/cm2, gE-I = 0.5 mS/cm2, respectively). [Colour ﬁgure can be viewed at wileyonlinelibrary.com].
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Mann & Mody, 2010; Oren et al., 2010; Jadi & Sejnowski, 2014).
Therefore, our data indicate a limited effect of carbachol on gamma
oscillations via modulation of inhibition possibly due to a lower
potency or efﬁcacy at the receptor subtypes regulating inhibition
(Jensen et al., 2003). In addition, our modelling predicts that
networks with high excitatory-to-inhibitory synaptic input ratio will
be resistant to modulations in gamma oscillation frequency (Fig. 7),
whereas those with a lower ratio will be less resistant suggesting
that different networks may vary in their frequency modulation. The
lack of a role for M3 mAChRs, which might otherwise be expected
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Fig. 8. M1 mAChRs are necessary and sufﬁcient for the effects of carbachol on theta-nested gamma oscillations. (A) Power spectral density plots for theta-
nested gamma oscillations with increasing concentrations of the M1 mAChR selective agonist GSK-5. (B) Gamma oscillation power but not peak frequency
was increased at low concentrations of GSK-5 (0.05 lM), but reduced at higher concentrations (1 and 3 lM) (n = 9 slices from six animals; P = 0.0164,
5.90 9 103 and 7.83 9 104 compared to baseline for 0.05, 1 and 3 lM, respectively, P > 0.05 for 0.1 and 0.3 lM; P > 0.05 for peak frequency at all con-
centrations). (C) Power spectral density plots for theta-nested gamma oscillations with increasing concentrations of carbachol in slices from M1 KO mice. (D)
There was no effect of carbachol on gamma oscillation power or peak frequency at any concentration of carbachol (n = 9 slices from six animals; P > 0.05 for
gamma power and peak frequency at all concentrations). *P < 0.05, ***P < 0.001.
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to perform a similar role to M1 mAChRs, is supported by the differ-
ential functional expression and distribution of M3 and M1
mAChRs within the hippocampus (Porter et al., 2002; Dennis et al.,
2015). Indeed, we found that the bidirectional modulation of gamma
oscillations could be explained entirely by enhancing the excitability
of PCs caused by activation of M1 mAChRs.
Optogenetic theta-frequency stimulation of entorhinal cortex or
hippocampus generates theta-nested gamma oscillations that exhibit
many important properties found in naturally occurring theta-nested
gamma including the relative timing of excitatory and inhibitory
neurons within the network (Pastoll et al., 2013; Butler et al.,
2016). In addition, as theta oscillation frequency and power may be
kept constant, optogenetically stimulated theta-nested gamma oscilla-
tions make an excellent model system to assess the modulation of
gamma oscillations. Similarly, the mathematical model enabled us to
probe the mechanism for cholinergic modulation of gamma oscilla-
tions by varying the known biophysical properties of cholinergic
receptor subtype activation producing predictions which were subse-
quently tested experimentally revealing the key role for M1
mAChRs. Although the mathematical model was based on experi-
mental biophysical parameters and recapitulated many of the core
experimental observations, it did diverge in some respects to the
experimental model most notably in the average gamma oscillation
frequency which was lower in the mathematical model and may
indicate potential differences between gamma oscillation mecha-
nisms exhibited in the mathematical and experimental models. How-
ever, the predictions provided by the mathematical model were
conﬁrmed in the experimental model indicating the validity of the
mathematical modelling approach.
Entrainment of neuronal activity to gamma oscillations is thought
to be critical for local circuit computations and the transfer of infor-
mation between brain regions (Colgin et al., 2009; Sohal et al.,
2009; Ainsworth et al., 2012). The coherence and frequency of
gamma oscillations are therefore critical for cognitive processing.
Neuromodulators represent an excellent mechanism for modulating
gamma oscillations and therefore regulating cognitive processing at
a local and global level. However, the mechanisms by which neuro-
modulators modulate gamma oscillations are poorly understood. In
this study we reveal that the neuromodulator acetylcholine modu-
lates the power but not frequency of gamma oscillations in the hip-
pocampus. This mechanism could work in tandem with the
modulation of theta oscillations to mediate the effects of acetyl-
choline on cognition (Lee et al., 1994; McGaughy et al., 2000;
Vandecasteele et al., 2014; Okada et al., 2015). Indeed optogeneti-
cally induced acetylcholine release enhances theta and gamma
power in the hippocampus of anaesthetised mice, but reduces power
in both bands in awake mice (Vandecasteele et al., 2014). Acetyl-
choline is released tonically in the hippocampus at high levels dur-
ing performance on cognitively demanding tasks and to a lesser
extent during REM sleep, but is generally very low during non-
REM sleep (or in the anaesthetised state) (Marrosu et al., 1995;
Teles-Grilo Ruivo et al., 2017). These observations suggest that
gamma oscillations may be regulated in a bidirectional manner
dependent on behavioural state.
Disruption to gamma oscillations is a prominent feature of
schizophrenia and Alzheimer’s disease. Cognitive control processes
correlate with modulation of gamma oscillations in healthy humans,
but this modulation is absent in schizophrenia (Cho et al., 2006).
The disruption to gamma oscillations in schizophrenia is believed to
result from a reduction in PV BC numbers and connectivity (Gonza-
lez-Burgos et al., 2015). In parallel, disruptions to gamma oscilla-
tions in Alzheimer’s disease are also thought to follow from a deﬁcit
in PV BCs and reversing these PV BC deﬁcits in animal models
reduces the associated cognitive deﬁcits (Verret et al., 2012). An
alternative strategy for cognitive enhancement could involve modula-
tion of gamma oscillations by agents that target neuromodulator sys-
tems. In this study we identify one such target as the M1 mAChR.
Interestingly, M1 agonists can enhance cognition in animals and
human models of cognitive deﬁcit (Bodick et al., 1997; Shirey et al.,
2009; Digby et al., 2012; Nathan et al., 2013) supporting M1
mAChRs as a potential therapeutic target. Furthermore, our data sug-
gest that the effects of any M1 mAChR agonist will be strongly dose
dependent. This and the high M1 mAChR reserve in the hippocam-
pus (Porter et al., 2002) will be important factors for the future
development of M1 agonists as cognitive enhancers.
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